SNAP-8 Research Overview (also known as Acetyl Glutamyl Heptapeptide-1, Acetyl Octapeptide-3, Anti-wrinkle octapeptide)
An octapeptide analog of the N-terminal end of SNAP-25 — a component of the SNARE protein complex responsible for acetylcholine release at the neuromuscular junction. By competing with SNAP-25 for SNARE complex assembly, SNAP-8 reduces neurotransmitter vesicle docking at the skin surface, attenuating muscle contraction intensity and the formation of expression lines.
What Is SNAP-8?
SNAP-8 (acetyl octapeptide-3) is a synthetic octapeptide designed to mimic the N-terminal sequence of SNAP-25, a key protein in the SNARE complex that governs synaptic vesicle fusion and neurotransmitter release at the neuromuscular junction. It was developed as a topical alternative to botulinum toxin for attenuating dynamic facial expression lines without injection.
Mechanism of Action
Muscle contraction at the skin surface — the physiological driver of expression lines — depends on acetylcholine being released from motor nerve terminals via SNARE-mediated vesicle fusion. The SNARE complex requires SNAP-25, synaptobrevin, and syntaxin to assemble correctly. SNAP-8 competitively occupies the SNAP-25 binding site on the SNARE complex, preventing complete assembly and reducing the efficiency of neurotransmitter vesicle docking. The result is a partial reduction in muscle contractile intensity — not complete paralysis as with botulinum toxin, but a measurable relaxation of repeated muscular expression patterns.
Clinical Research
SNAP-8 has been studied in clinical trials for periorbital and glabellar expression lines. In a double-blind placebo-controlled study, topical application of 10% SNAP-8 reduced the appearance of expression wrinkles by approximately 63% compared to placebo after 28 days of twice-daily use.
Comparison with Argireline
SNAP-8 is the 8-amino-acid extended version of Argireline (hexapeptide-3), which targets the same SNARE pathway. SNAP-8 is believed to have a more pronounced effect due to its longer interaction surface with SNARE complex proteins.
Quick Reference
| Literature-Reported Dose Range | 3-10% concentration in final formulation |
| Literature-Reported Frequency | Twice daily (morning and evening) |
| Literature-Reported Cycle Length | Continuous use - effects require ongoing application |
| Literature-Reported Washout | No cycling required - safe for long-term continuous use |
| Storage | Solution at 4°C (refrigerated); powder at room temperature in cool, dark place |
| Timing | After cleansing, before moisturizer |
Research Indications
Anti-Wrinkle
Expression Line Reduction
Clinical studies demonstrate up to 63% reduction in wrinkle depth around the eyes and forehead with consistent application over 28 days
Forehead Wrinkle Treatment
Effectively targets horizontal forehead lines caused by repetitive muscle contractions from raising eyebrows and facial expressions
Crow's Feet Improvement
Reduces periorbital wrinkles (crow's feet) through localized muscle relaxation without affecting natural facial expressions
Muscle Relaxation
SNARE Complex Modulation
Competitively inhibits SNARE complex formation at 43% efficiency at therapeutic concentrations, reducing acetylcholine release
Targeted Muscle Action
Provides localized muscle relaxation when applied topically, specifically targeting areas of dynamic wrinkle formation
Gradual Effect
Unlike Botox, effects develop gradually over 2-4 weeks with consistent application, providing subtle and natural-looking results
Skin Health
Preventive Anti-Aging
Can be used preventively to slow formation of new expression lines before they become deeply etched static wrinkles
Hydration Support
Often formulated with hyaluronic acid and other hydrating ingredients for comprehensive anti-aging benefits
Safe for Sensitive Areas
Well-tolerated around delicate eye area where expression lines commonly form, with minimal irritation risk
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| General Anti-Aging | 3-5% concentration | 2x daily | Topical serum/cream |
| Intensive Wrinkle Treatment | 5-10% concentration | 2x daily | Targeted application |
| Eye Area Treatment | 3-5% concentration | 2x daily | Eye cream/serum |
| Forehead Lines | 5-10% concentration | 2x daily | Direct application |
| Preventive Use | 3% concentration | 1-2x daily | Daily moisturizer |
Timing
Recommended administration window: after cleansing, before moisturizer. Typical onset: 7 days: early smoothing; 28 days: significant reduction; 8+ weeks: maximum results.
Peptide Interactions
Parent compound of SNAP-8 with same mechanism. Can be combined for enhanced effect, but may be redundant as SNAP-8 is approximately 30% more potent
Research shows synergistic effects when combined at equal concentrations (0.75 mM each), producing 47% total inhibition compared to 38% and 7% independently
Complementary mechanisms - SNAP-8 reduces expression lines while GHK-Cu promotes collagen synthesis. Safe to use in same routine with proper timing
Excellent combination - hyaluronic acid provides hydration and plumping effects while SNAP-8 addresses dynamic wrinkles. Often formulated together
Safe combination that works well together. Niacinamide calms and strengthens skin barrier while SNAP-8 targets expression lines
Both are potent actives. Retinol can increase skin sensitivity and may cause irritation when combined. Introduce slowly or use at different times (SNAP-8 morning, retinol evening)
May interact due to pH differences. Use Vitamin C in the morning and SNAP-8 at night to avoid potential stability issues and maximize efficacy
Glycolic acid and salicylic acid can destabilize peptides and reduce effectiveness. Use at different times - acids in morning, peptides in evening
Complementary anti-aging peptides - Matrixyl stimulates collagen production while SNAP-8 relaxes muscles. Commonly combined in anti-aging formulations
Can be used together but copper peptides combined with retinol are not advised. When using both SNAP-8 and copper peptides, avoid retinol in the same routine
Reported Research Timeline
01Day 1–7 (reported in cited studies): skin may feel slightly smoother; minimal visible changes
02Week 2–3 (reported in cited studies): initial reduction in fine lines; skin appears more relaxed
03Week 4 (reported in cited studies): significant wrinkle depth reduction (up to 35% average)
04Week 6–8 (reported in cited studies): maximum efficacy achieved (up to 63% reduction)
05Ongoing (reported in cited studies): maintained results with continued use; effects diminish if discontinued
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Perform patch test 24 hours before first facial use
Generally well-tolerated even on sensitive skin and delicate eye area
Mild irritation may occur initially at higher concentrations (5-10%)
Avoid combining with strong acids (AHAs/BHAs) in the same application
If using retinol, introduce SNAP-8 slowly and consider alternating evenings
Not intended for use during pregnancy or breastfeeding
Discontinue if persistent irritation occurs
Seek Medical Attention If:
Persistent skin irritation, burning, or redness
Allergic reaction: rash, hives, swelling, or difficulty breathing
Unusual skin discoloration in treated areas
Worsening of skin condition after 2+ weeks of use
Eye irritation if product gets into eyes
Quality Indicators
Verified Marker
Clear, colorless solution
SNAP-8 solution should be clear and colorless to slightly yellowish with no visible particles or cloudiness
Verified Marker
pH between 3.0-5.0
Optimal pH range for stability and skin compatibility. Products outside this range may indicate degradation
Verified Marker
Proper packaging
Should be in airless pump, dark glass, or UV-protected container to prevent degradation from light and air
Verified Marker
Gradual visible results
Quality SNAP-8 produces subtle but measurable wrinkle reduction over 2-4 weeks of consistent use
Acceptable Range
Concentration verification
Many commercial products contain subtherapeutic concentrations. Look for products specifying 3-10% SNAP-8 solution
Quality Concern
Cloudy or discolored solution
Indicates degradation, contamination, or improper storage - product should be discarded
Research Citations
- The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study
Wang, Y., Wang, M., Xiao, S., Pan, P., Li, P., Huo, J., 2013, American Journal of Clinical Dermatology - A synthetic hexapeptide (Argireline) with antiwrinkle activity
Blanes-Mira, C., Clemente, J., Jodas, G., et al., 2002, International Journal of Cosmetic Science - Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy
Errante, F., Ledwón, P., Latajka, R., et al., 2020, Molecules - Method development for acetyl octapeptide-3 analysis by liquid chromatography-tandem mass spectrometry
Ji, M., Lee, H.S., Kim, Y., et al., 2020, Journal of Analytical Science and Technology - Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects
Shin, J.Y., Han, D., Yoon, K.Y., Jeong, D.H., Park, Y.I., 2024, Annals of Dermatology - Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review
Pintea, A., Manea, A., Pintea, C., et al., 2025, Biomolecules
Research Focus
Anti-aging, Wrinkle reduction, Expression line attenuation, Cosmetic applications, Dermatology
Verified Vendors Carrying SNAP-8
Frequently Asked Questions
What should researchers watch for with SNAP-8?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with SNAP-8?
Day 1–7 (reported in cited studies): skin may feel slightly smoother; minimal visible changes
How is SNAP-8 typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →